Sumatriptan Succinate Injection should be used with caution in patients with a history of epilepsy or conditions associated with a lowered seizure threshold.The following serious adverse reactions are described below and elsewhere in the labeling:Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared with rates in the clinical trials of another drug and may not reflect the rates observed in practice.The incidence of adverse reactions in controlled clinical trials was not affected by gender or age of the patients. Call your doctor for medical advice about side effects. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function and of concomitant disease or other drug therapy.A cardiovascular evaluation is recommended for geriatric patients who have other cardiovascular risk factors (e.g., diabetes, hypertension, smoking, obesity, strong family history of CAD) prior to receiving Sumatriptan Succinate Injection Coronary vasospasm was observed after intravenous administration of Sumatriptan Succinate Injection The elimination half-life of sumatriptan is about 2 hours It is unknown what effect hemodialysis or peritoneal dialysis has on the serum concentrations of sumatriptan.Sumatriptan Succinate Injection contains sumatriptan succinate, a selective 5-HTSumatriptan Succinate Injection is a clear, colorless to pale yellow, sterile, nonpyrogenic solution for subcutaneous injection. The maximum single recommended adult dose of Imitrex Injection for the acute treatment of migraine or cluster headache is 6 mg injected subcutaneously. In general, anaphylactic reactions to drugs are more likely to occur in individuals with a history of sensitivity to multiple allergens Inform patients that use of Sumatriptan Succinate Injection within 24 hours of another triptan or an ergot-type medication (including dihydroergotamine or methysergide) is contraindicated Caution patients about the risk of serotonin syndrome with the use of Sumatriptan Succinate Injection or other triptans, particularly during combined use with SSRIs, SNRIs, TCAs, and MAO inhibitors Inform patients that use of acute migraine drugs for 10 or more days per month may lead to an exacerbation of headache and encourage patients to record headache frequency and drug use (e.g., by keeping a headache diary) Advise patients to notify their healthcare provider if they become pregnant during treatment or plan to become pregnant Advise patients to notify their healthcare provider if they are breastfeeding or plan to breastfeed Treatment with Sumatriptan Succinate Injection may cause somnolence and dizziness; instruct patients to evaluate their ability to perform complex tasks after administration of Sumatriptan Succinate Injection.Instruct patients to read the Instructions for Use before starting therapy.


Select one or more newsletters to continue. Instruct patients on the proper use of the autoinjector pen and direct them to use injection sites with an adequate skin and subcutaneous thickness to accommodate the length of the needle.The needle shield of the prefilled syringe contains dry natural rubber (a latex derivative) In patients receiving doses other than 4 mg or 6 mg, use the 6-mg single-dose vial; do not use the autoinjector pen.
There have been rare reports of serious cardiac adverse reactions, including acute myocardial infarction, occurring within a few hours following administration of Sumatriptan Succinate Injection.

You and your healthcare provider should talk about Sumatriptan Succinate Injection when you start taking it and at regular checkups.Keep the Sumatriptan Succinate Injection Kit out of the reach of children.Put your used syringe cartridge pack in a FDA-cleared sharps disposal container right away after use This Patient Information and Instructions for Use has been approved by the U.S. Food and Drug Administration.Brands listed are trademarks of their respective owners.The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records.